Tci Wealth Advisors, Inc. Idera Pharmaceuticals, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 29, 2021	SELL	$1.23 - $5.98 $4,920 - $23,920	-4,000 Closed	0 $0
Q3 2019 Oct 17, 2019	SELL	$2.12 - $3.31 $212 - $331	-100 Reduced 2.44%	4,000 $12,000
Q2 2019 Jul 23, 2019	SELL	$2.37 - $3.97 $237 - $397	-100 Reduced 2.38%	4,100 $11,000
Q4 2018 Jan 17, 2019	BUY	$2.77 - $9.38 $8,484 - $28,730	3,063 Added 269.39%	4,200 $12,000
Q3 2018 Nov 02, 2018	BUY	$5.53 - $11.36 $6,287 - $12,916	1,137 New	1,137 $10,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.